elbows
Well-Known Member
NERVTAG minutes November 25th (published on the 29th):
Some quotes:
Box
app.box.com
Some quotes:
SA estimates an R-value of 1.9 for B.1.1.529 in Gauteng.
The R-value estimate of 1.9 is occurring against a background of high levels of immunity following the recent wave (wave number 3) of Delta variant infections in SA and an active immunisation programme.
Although there is not yet any direct experimental evidence of immune escape, the genotype and the epidemiology in SA are highly suggestive that B.1.1.529 is an antigenically divergent variant that is able to successfully infect previously infected or vaccinated individuals.
There are currently insufficient data to make any comments on disease severity associated with B.1.1.529.
Conclusion: the subgroup concludes that if introduced into the UK, B.1.1.529 would likely be capable of initiating a new wave of infections. We cannot exclude that this wave would be of a magnitude similar, or even larger, than previous waves.
Conclusion: Although data on disease severity associated with B.1.1.529 are not yet available, a large wave of infections will be accompanied by a wave of severe cases and the subgroup cannot rule out that this may be sufficient to overwhelm NHS capacity
Although computational analyses are ongoing, the multiple mutations observed in theB.1.1.529 spike glycoprotein are likely to render many of the currently available monoclonal antibodies ineffective.
Acceleration of the vaccine boosting campaign should be considered, which might provide some residual or significant VE against B1.1.529, and at a minimum would help control concurrent Delta impact.